Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Puffpuff02on Nov 18, 2020 10:34pm
806 Views
Post# 31928433

Aphria Stock Valuation Is Now Reasonable

Aphria Stock Valuation Is Now Reasonable

Aphria stock boasts a price-sales ratio of 3.4. This is very little hopium that the bulls expect out of it. It’s is three times cheaper than Facebook (NASDAQ:FB) and over 24 times cheaper than Zoom (NASDAQ:ZM) to offer two absolute examples.

There might be a problem with optics though.

Cannabis stocks have to compete with headlines that are coming from the cloud stocks that are too fantastic. It’s easy for tech to steal the attention when Zoom and Nio(NYSE:NIO) grow sales 350% and 160% respectively. Aphria’s sales growth is impressive year over year, but is not as flashy on a quarterly basis.

To put it simply, they were the hot topic of 2018 and now they are out of the limelight. But therein lies the opportunity. We know that Wall Street likes to trade based on headlines. Once they get their teeth into a prevailing thesis, they chase it to death. The best way to capitalize on this is to find those topics before they become popular. Pot stocks could be the sleeper headline of 2021.

 

Aphria stock has just rallied off of a solid base above $5 per share. From a trading perspective, it would make better sense to buy it on the next dip. The range is tightening, so there will be a move soon. If investors want to wear their trader hats they should either buy the dip or buy the rip. Meaning if the dip doesn’t come, then it’s surely breaking out soon. The idea is to either buy it above its most recent fail, or buy it on its next bad day. One is a momentum’s trade, the other one is a fundamental one.

You Have to Be in it to Win it

Those who want to own the stock for the long term should just do that. This would fit with the logic I’m suggesting today, and the weekly chart says to do it. There will come a time next year when CNBC will be covering pot stocks every day once again. It looks like we’re getting a new administration that is almost guaranteed to bring up legalization.

Currently the laws don’t allow for much consolidation, so most traditional corporations are not wading into cannabis. Take that away and you open up a giant door for new money.

The explosion of EV stocks proves that money on the sidelines is itching to jump in on a theme. It is logical to expect cannabis to recapture the imagination of buyers sooner rather than later.

Make no mistake about it, it is still a speculative proposition. But public opinion is warming up to the idea. I live in California and the conversation about cannabis even in my house has completely changed. This will propagate and replicate in other states and it all spells upside potential. I bet alcoholic beverages faced a similar path to normalcy.

There are extrinsic factors that could hinder the progress. For example, stocks in general are too hot and are vulnerable to pullbacks. This alone is not a reason to short APHA stock, but it is reason for caution. Taking trades in tranches here makes sense and leaves room to manage risk. CGC is the logical choice for a bet on pot stocks, so splitting bets could be good. But as they say — no risk, no reward. Aphria carries a bit more risk and therefore should have the bigger reward. They will move in tandem for the most part otherwise.


<< Previous
Bullboard Posts
Next >>